OUTCOMES AND TOXICITY PROFILE IN ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS (DLBCL): A REAL-WORLD AND COMPARATIVE STUDY INVOLVING THREE DIFFERENT DOSE-MODULATED ANTHRACYCLINE-BASED IMMUNOCHEMOTHERAPY REGIMENS IN LATAM LAPC Lage; RN Vita; CO Reichert; HF Culler; FA Freitas; LBO Alves; V Rocha; SAC Siqueira; RO Costa; J Pereira;

DOES PERIPHERAL BLOOD MIRROR IMMUNE TUMOR MICROENVIRONMENT? FLOW CYTOMETRY QUANTIFICATION OF PERIPHERAL BLOOD LYMPHOCYTE SUBPOPULATIONS AND OUTCOMES IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) LAPC Lage; ICTS Almeida; CO Reichert; GG Lima; HF Culler; FA Freitas; V Rocha; RO Costa; SAC Siqueira; J Pereira;

UP-FRONT ASCT OVERCOMES THE SURVIVAL BENEFIT PROVIDED BY HDAC-BASED INDUCTION REGIMENS IN MANTLE CELL LYMPHOMA: DATA FROM A REAL-LIFE AND LONG-TERM COHORT LAPC Lage; MED Vale; CO Reichert; HF Culler; RO Costa; FA Freitas; V Rocha; SAC Siqueira; J Pereira;